2012
DOI: 10.1016/j.ymeth.2012.06.006
|View full text |Cite
|
Sign up to set email alerts
|

Yeast “N”-hybrid systems for protein–protein and drug–protein interaction discovery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
18
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(18 citation statements)
references
References 31 publications
0
18
0
Order By: Relevance
“…Since its development, the three-hybrid method has been successfully used to identify many protein-small molecule interactions [33, 34]. Very recently, the three-hybrid approach has been used to identify proteins that bind to the drugs erlotinib, atorvastatin, and sulfasalazine [35], the glaucoma therapeutic anecortave acetate [36], and a panel of anti-tuberculosis drugs [37].…”
Section: Methods For Identifying Small Molecule-interacting Cellulamentioning
confidence: 99%
“…Since its development, the three-hybrid method has been successfully used to identify many protein-small molecule interactions [33, 34]. Very recently, the three-hybrid approach has been used to identify proteins that bind to the drugs erlotinib, atorvastatin, and sulfasalazine [35], the glaucoma therapeutic anecortave acetate [36], and a panel of anti-tuberculosis drugs [37].…”
Section: Methods For Identifying Small Molecule-interacting Cellulamentioning
confidence: 99%
“…As a consequence, several technologies have been developed, including yeast twohybrid (Y2H), reverse yeast two-hybrid (Rezwan and Auerbach, 2012), bacteria two-hybrid (Stynen et al , 2012), Mammalian Protein-Protein Interaction Trap (MAPPIT) , reverse MAPPIT (Lemmens et al , 2006), bimolecular fluorescence complementation (BiFC), and FRET-and BRETbased methods (Ciruela, 2008;Corbel et al , 2011).…”
Section: Protein-protein Interactions (Ppis)mentioning
confidence: 99%
“…Selection at 10 nM, approximately twofold above the LD 50 for parental HCT-116 cells, was conducted to obtain six resistant clones for further analysis. 32 BI 2536, 12, a Polo-like-kinase 1 (PLK1) inhibitor currently undergoing clinical trials, was used to select for resistant HCT-116 colon cancer cells.…”
Section: Transcriptome Sequencing To Identify Mechanisms Of Drug Actimentioning
confidence: 99%
“…These typically are ligands with high affinity 47 to, or substrates that can covalently bind 48 to, a genetically encoded enzyme "hook." 50 The reporter gene amplifies the signal ensuring that unstable targets as well as low affinity transient interactions can be detected. The bifunctional bait upon entry into the nucleus can associate with the hook, creating a preorganized bait scaffold displayed on the promoter region.…”
Section: Yeast Three-hybrid Systemmentioning
confidence: 99%